A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma

Background. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with rapid tumor progression and poor prognosis. This study was motivated by the lack of sensitive and specific PDAC biomarkers and aimed to identify a diagnostic, serum protein signature for PDAC. Methods. To mimic a real...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Proteomics
Main Authors: Gerdtsson, Anna S., Malats, Núria, Säll, Anna, Real, Francisco X., Porta, Miquel, Skoog, Petter, Persson, Helena, Wingren, Christer, Borrebaeck, Carl A. K.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4637476/
https://ncbi.nlm.nih.gov/pubmed/26587286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/587250
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados